Skip to content

A Pilot Evaluation of Adhesives and How They Are Impacted by Out-put

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02610907
Enrollment
4
Registered
2015-11-20
Start date
2015-11-30
Completion date
2016-01-31
Last updated
2016-01-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ileostomy

Brief summary

The study investigates the impact real output (subjects own) and simulated output have on the adhesion of adhesives.

Interventions

OTHERBuffer

The sleeve contains phosphate buffered saline buffer

OTHEROwn output

The sleeve contains the subject own ileal effluent

OTHERsimulated output

The sleeve contains simulated output

Sponsors

Coloplast A/S
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Have given written informed consent 2. Be at least 18 years of age and have full legal capacity 3. Have had an ileostomy for more than one year 4. Have intact skin on the area used in the evaluation 5. Has an ileostomy with a diameter up to (≤) 35 mm 6. Have a peristomal area accessible for application of patches/adhesive strips (assessed by investigating scientist)

Exclusion criteria

1. Currently receiving or have within the past 2 month received radio- and/or chemotherapy 2. Currently receiving or have within the past month received topical steroid treatment in the peristomal skin area or systemic steroid (tablet/injection) treatment. 3. Are pregnant or breastfeeding 4. Having dermatological problems in the peristomal- or abdominal area (assessed by investigating scientist) 5. Participating in other interventional clinical investigations or have previously participated in this evaluation

Design outcomes

Primary

MeasureTime frameDescription
Remaining adhesive area of adhesive30 hoursThe remaining adherent area of the adhesive is assessed by subtracting the area of output and swelling from the total adhesive area.

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026